Skip to main content
. 2021 Sep 18;61(8):1211–1217. doi: 10.2169/internalmedicine.7300-21

Table 2.

The Serum Test Results at the Time of Admission to Our Department.

WBC 6,500 /µL Na 140 mEq/dL
Neut 71.6 % K 4.8 mEq/dL
Eo 3 % TP 5.5 g/dL
Baso 0.3 % Alb 2.5 g/dL
Mono 9.8 % CRP 5.33 mg/dL
Lymp 12.4 % βD-Glucan <6.0 pg/mL
RBC 3.27×104 /µL KL-6 1,906 U/mL
Hb 9.5 g/dL SP-D 230 ng/mL
Plt 25.9×104 /µL RF <10 IU/mL
AST 46 U/L ANA <40 times
ALT 18 U/L anti-SS-A antibody (-)
ALP 659 U/L PR3-ANCA <1.0 IU/mL
LDH 189 U/L MPO-ANCA <1.0 IU/mL
γ-GTP 104 U/L CMV anitigen* 0 cells/2 slides
BUN 22 mg/dL T-SPOT (-)
Cre 1.29 mg/dL

WBC: white blood cell, Neut: neutrophil, Eo: eosinophil, Baso: basophil, Mono: monocyte, Lymp: lymphocyte, RBC: red blood cell, Hb: hemoglobin, Plt: platelet count, AST: aspartate aminotransferase, ALT: alanine aminotransferase, ALP: alkaline phosphatase, LDH: lactate dehydrogenase, γ-GTP: γ-glutamyl transpeptidase, BUN: blood urea nitrogen, Cre: creatinine, TP: total protein, Alb: albumin, CRP: C-reactive protein, βD-Glucan: beta-d-glucan , KL-6: krebs von den lugen-6, SP-D: surfactant protein D, RF: rheumatoid factor, ANA: antinuclear antibody, anti-SS-A antibody: anti-Sjögren’s-syndrome-related antigen A autoantibodies, PR3-ANCA: proteinase3 antineutrophil cytoplasmic antibody, MPO-ANCA: myeroperoxidase antineutrophil cytoplasmic antibody, CMV antigen: cytomegalovirus antigen, T-SPOT: T-SPOT®-TB

* cytomegalovirus, viral antigen (pp65. C10, C11)